Ned Tijdschr Geneeskd. 2009;153:A771.

[Combating the new influenza A (H1N1) virus. II. Surveillance and non-pharmaceutical interventions].

[Article in Dutch]

van der Sande MA, van der Hoek W, Hooiveld M, Donker GA, van Steenbergen JE, van Boven M, Wallinga J.

Source

Rijksinstituut voor Volksgezondheid en Milieu, Centrum Infectieziektebestrijding, Bilthoven, The Netherlands. marianne.van.der.sande@rivm.nl

Abstract

Intensive surveillance in Mexico, the US, Canada, Spain and the UK has resulted in the first data on the new influenza A (H1N1) virus. As of yet, it is still unknown if, how and where further transmission within the Netherlands will take place. Therefore, intensified surveillance in the Netherlands is essential. Information on individual patients and their contacts is available through the compulsory notification of the new influenza. The number of general practitioners and nursing homes participating in surveillance through national networks is extended. In addition mortality statistics and internet-based surveillance are being used (the Dutch Great Influenza Survey). Based on studies on previous flu epidemics and mathematical models we can estimate the expected effect of non-pharmaceutical interventions.The reduction of social contacts, in particular through the closure of schools, hand washing routines and wearing of facemasks if done correctly, are expected to be effective non-pharmaceutical interventions in slowing the transmission of the new influenza virus.

PMID:: 19785810; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review [Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]. [Ned Tijdschr Geneeskd. 2009]
Review [Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects].
Koopmans MP, Meijer A, van der Lubben MI, Boucher C, Fouchier RA, Osterhaus AD, Timen A, de Jong MD, van Steenbergen JE. Ned Tijdschr Geneeskd. 2009; 153:A770.
Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). [PLoS One. 2010]
Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1).
Tracht SM, Del Valle SY, Hyman JM. PLoS One. 2010 Feb 10; 5(2):e9018. Epub 2010 Feb 10.
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. [Euro Surveill. 2009]
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study.
Sypsa V, Hatzakis A. Euro Surveill. 2009 Jun 18; 14(24). Epub 2009 Jun 18.
Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. [Euro Surveill. 2009]
Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.
Hahné S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A, van der Sande M, Koopmans M, Wallinga J, Coutinho R, et al. Euro Surveill. 2009 Jul 9; 14(27). Epub 2009 Jul 9.
Review Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. [BMC Public Health. 2007]
Review Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base.
Aledort JE, Lurie N, Wasserman J, Bozzette SA. BMC Public Health. 2007 Aug 15; 7:208. Epub 2007 Aug 15.

See reviews... See all...

Cited by 1 PubMed Central article

Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. [PLoS Med. 2011]
Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis.
Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, et al. PLoS Med. 2011 Jul; 8(7):e1001053. Epub 2011 Jul 5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

[Combating the new influenza A (H1N1) virus. II. Surveillance and non-pharmaceut...
[Combating the new influenza A (H1N1) virus. II. Surveillance and non-pharmaceutical interventions].
Ned Tijdschr Geneeskd. 2009 ;153:A771.

PubMed
Expression of aminopeptidase N (CD13) in mesenchymal tumors.
Expression of aminopeptidase N (CD13) in mesenchymal tumors.
Am J Pathol. 1990 Nov ;137(5):1215-22.

PubMed
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy o...
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
HIV Med. 2009 Oct ;10(9):527-35.

PubMed
Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in...
Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations.
Am J Hum Genet. 1990 Dec ;47(6):968-72.

PubMed
The role of human endogenous retroviruses in melanoma.
The role of human endogenous retroviruses in melanoma.
Br J Dermatol. 2009 Dec ;161(6):1225-31. Epub 2009 Jul 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: